NCT00415324View on ClinicalTrials.gov

Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2014

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

eribulin mesylate

Given IV

DRUG

cisplatin

Given IV

OTHER

laboratory biomarker analysis

correlative study

OTHER

pharmacological study

correlative study

Trial Locations (4)

90033

University of Southern California/Norris Cancer Center, Los Angeles

91010

City of Hope Medical Center, Duarte

City of Hope, Duarte

95817

University of California at Davis Cancer Center, Sacramento

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00415324 - Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter